Abstract:NDRG1 is known to play important roles in both androgen-induced cell differentiation and inhibition of prostate cancer metastasis. However, the proteins associated with NDRG1 function are not fully enumerated. Using coimmunoprecipitation and mass spectrometry analysis, we identified 58 proteins that interact with NDRG1 in prostate cancer cells. These proteins include nuclear proteins, adhesion molecules, endoplasmic reticulum (ER) chaperons, proteasome subunits, and signaling proteins. Integration of our data with protein-protein interaction data from the Human Proteome Reference Database allowed us to build a comprehensive interactome map of NDRG1. This interactome map consists of several modules such as a nuclear module and a cell membrane module; these modules explain the reported versatile functions of NDRG1. We also determined that serine 330 and threonine 366 of NDRG1 were phosphorylated and demonstrated that the phosphorylation of NDRG1 was prominently mediated by protein kinase A (PKA). Further, we showed that NDRG1 directly binds to beta-catenin and E-cadherin. However, the phosphorylation of NDRG1 did not interrupt the binding of NDRG1 to E-cadherin and beta-catenin. Finally, we showed that the inhibition of NDRG1 expression by RNA interference decreased the ER inducible chaperon GRP94 expression, directly proving that NDRG1 is involved in the ER stress response. Intriguingly, we observed that many members of the NDRG1 interactome are androgen-regulated and that the NDRG1 interactome links to the androgen response network through common interactions with P-catenin and heat shock protein 90. Therefore we overlaid the transcriptomic expression changes in the NDRG1 interactome in response to androgen treatment and built a dual dynamic picture of the NDRG1 interactome in response to androgen. This interactome map provides the first road map for understanding the functions of NDRG1 in cells and its roles in human diseases, such as prostate cancer, which can progress from androgen-dependent curable stages to androgen-independent incurable stages.

NDRG2 Acts As a Negative Regulator Downstream of Androgen Receptor and Inhibits the Growth of Androgen-Dependent and Castration-Resistant Prostate Cancer

Suppression of Invasion and Metastasis of Prostate Cancer Cells by Overexpression of NDRG2 Gene.

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

Inhibition of N-myc downstream-regulated gene 2 in prostatic carcinoma

NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498

NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the PTEN-AKT-mTOR signalling cascade

Inactivation of AR/TMPRSS2-ERG/Wnt Signaling Networks Attenuates the Aggressive Behavior of Prostate Cancer Cells

Orphan Nuclear Receptor TLX Contributes to Androgen Insensitivity in Castration-Resistant Prostate Cancer Via Its Repression of Androgen Receptor Transcription.

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer

CAMK2N1 Inhibits Prostate Cancer Progression Through Androgen Receptor-Dependent Signaling

Ndrg3 Is An Androgen Regulated And Prostate Enriched Gene That Promotes In Vitro And In Vivo Prostate Cancer Cell Growth

ROR-[gamma] drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer

Combination of the NRF2 Inhibitor and Autophagy Inhibitor Significantly Inhibited Tumorigenicity of Castration-Resistant Prostate Cancer

Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer

N-Myc Downstream-Regulated Gene 2 (NDRG2) As a Novel Tumor Suppressor in Multiple Human Cancers

RNF8 Up-Regulates AR/ARV7 Action to Contribute to Advanced Prostate Cancer Progression.

Abstract #1185: Loss of N-myc Downstream-Regulated Gene 1 (NDRG1) Increases Prostate Cancer Cell Invasion by Upregulating CCL5

Proteomics Analysis of the Interactome of N-myc Downstream Regulated Gene 1 and Its Interactions with the Androgen Response Program in Prostate Cancer Cells

CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression

Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion

Lipocalin 2 Over-Expression Facilitates Progress of Castration-Resistant Prostate Cancer Via Improving Androgen Receptor Transcriptional Activity